A former New Zealand journalist who lives in Washington, DC
David Young investigates the opioid crisis in North America. Are new approaches and more resources needed? What form should they take?
With medicinal cannabis legal in the majority of states and more and more legalising recreational use, opportunities now abound for a wide variety of new entrepreneurs and established big business.
Just a few months into the new Trump-led America, there’s no clear indication yet as to where his administration will stand on drug law reform.
Eradication attacks on Colombian drug crops have been hailed by many (including the White House) as a success. David Young looks at the local cost.
Just after his resignation as Minister of State for the Home Office responsible for the drugs portfolio in November 2014, British MP Norman Baker talked to David Young about drug policy in the UK and the widespread mood for reform.
Alcohol-related harm in the UK was at the forefront of Prime Minister Cameron’s sights when he came into office, but now the situation is a bit more murky. David Young and Shannon Hanrahan investigate the politics of minimum price.
Today, more than ever, armies around the world are dealing with serious substance abuse problems and the mental health issues that result. New Zealand is no exception.
At $1 billion, New Zealand's cannabis black market would equate to one quarter the size of New Zealand's entire legal horticulture industry. David Young explores whether the economics are that simple